Co-Authors
                            
                            
                                This is a "connection" page, showing publications co-authored by   Jason Glanz   and   Jennifer Nelson.
                            
                            
                            
                                
                                    
                                            
    
        
        
        
            Connection Strength
            
                
            
            0.851
         
        
        
     
 
    
        
        - 
            Signal detection of adverse events with imperfect confirmation rates in vaccine safety studies using self-controlled case series design. Biom J. 2014 May; 56(3):513-25.
            
            
                Score: 0.112
            
         
        
        - 
            Association between undervaccination with diphtheria, tetanus toxoids, and acellular pertussis (DTaP) vaccine and risk of pertussis infection in children 3 to 36 months of age. JAMA Pediatr. 2013 Nov; 167(11):1060-4.
            
            
                Score: 0.110
            
         
        
        - 
            A population-based cohort study of undervaccination in 8 managed care organizations across the United States. JAMA Pediatr. 2013 Mar 01; 167(3):274-81.
            
            
                Score: 0.105
            
         
        
        - 
            Use of Fixed Effects Models to Analyze Self-Controlled Case Series Data in Vaccine Safety Studies. J Biom Biostat. 2012 Apr 19; Suppl 7:006.
            
            
                Score: 0.099
            
         
        
        - 
            Identifying optimal risk windows for self-controlled case series studies of vaccine safety. Stat Med. 2011 Mar 30; 30(7):742-52.
            
            
                Score: 0.090
            
         
        
        - 
            Risk of myocarditis and pericarditis following BNT162b2 and mRNA-1273 COVID-19 vaccination. Vaccine. 2022 08 19; 40(35):5153-5159.
            
            
                Score: 0.050
            
         
        
        - 
            Changes in incidence rates of outcomes of interest in vaccine safety studies during the COVID-19 pandemic. Vaccine. 2022 05 20; 40(23):3150-3158.
            
            
                Score: 0.050
            
         
        
        - 
            Surveillance for Adverse Events After COVID-19 mRNA Vaccination. JAMA. 2021 Sep 03.
            
            
                Score: 0.047
            
         
        
        - 
            COVID-19 Vaccination Coverage Among Insured Persons Aged =16 Years, by Race/Ethnicity and Other Selected Characteristics - Eight Integrated Health Care Organizations, United States, December 14, 2020-May 15, 2021. MMWR Morb Mortal Wkly Rep. 2021 Jul 16; 70(28):985-990.
            
            
                Score: 0.047
            
         
        
        - 
            Evaluating the Association of Stillbirths After Maternal Vaccination in the Vaccine Safety Datalink. Obstet Gynecol. 2020 12; 136(6):1086-1094.
            
            
                Score: 0.045
            
         
        
        - 
            Safety of repeated doses of tetanus toxoid, reduced diphtheria toxoid, and acellular pertussis vaccine in adults and adolescents. Pharmacoepidemiol Drug Saf. 2018 Aug; 27(8):921-925.
            
            
                Score: 0.038
            
         
        
        - 
            Timely versus delayed early childhood vaccination and seizures. Pediatrics. 2014 Jun; 133(6):e1492-9.
            
            
                Score: 0.029
            
         
        
        - 
            Safety of diphtheria, tetanus, acellular pertussis and inactivated poliovirus (DTaP-IPV) vaccine. Vaccine. 2014 May 23; 32(25):3019-24.
            
            
                Score: 0.028